| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Silymarin | Alzheimer's Disease | 2 | PM | 38353101 | 📋 | Adjunctive silymarin supplementation and its effects on disease severity, oxidative stress, and inflammation in patients with Alzheimer's disease |
| Silymarin | Alzheimer's Disease | 3 | PM | 32932753 | 📋 | The Possible Neuroprotective Effect of Silymarin against Aluminum Chloride-Prompted Alzheimer's-Like Disease in Rats |
| Silymarin | Alzheimer's Disease | 1 | PM | 32044368 | 📋 | Silymarin Encapsulated Nanoliquid Crystals for Improved Activity Against Beta Amyloid Induced Cytotoxicity |
| Silymarin | Beta-Thalassemia | 8 | PM | 38818907 | 📋 | The Effects and Safety of Silymarin on β-thalassemia in Children and Adolescents: A Systematic Review based on Clinical Trial Studies |
| Silymarin | Beta-Thalassemia | 2 | PM | 32971524 | 📋 | Can Use of Silymarin Improve Inflammatory Status in Patients with β-Thalassemia Major? A Crossover, Randomized Controlled Trial |
| Silymarin | Beta-Thalassemia | 3 | PM | 29235162 | 📋 | Iron-chelating Effect of Silymarin in Patients With β-Thalassemia Major: A Crossover Randomised Control Trial |
| Silymarin | Beta-Thalassemia | 7 | PM | 29154063 | 📋 | The impact of silymarin on antioxidant and oxidative status in patients with β-thalassemia major: A crossover, randomized controlled trial |
| Silymarin | Beta-Thalassemia | 6 | PM | 24363880 | 📋 | Therapeutic value of combined therapy with deferasirox and silymarin on iron overload in children with Beta thalassemia |
| Silymarin | Beta-Thalassemia | 5 | PM | 23624215 | 📋 | Immunomodulatory effects of silymarin in patients with β-thalassemia major |
| Silymarin | Beta-Thalassemia | 4 | PM | 23278124 | 📋 | A randomized double-blind, placebo-controlled study of therapeutic effects of silymarin in β-thalassemia major patients receiving desferrioxamine |
| Silymarin | Beta-Thalassemia | 1 | PM | 19453758 | 📋 | Combined Therapy of Silymarin and Desferrioxamine in Patients With Beta-Thalassemia Major: A Randomized Double-Blind Clinical Trial |
| Silymarin | Familial Adenomatous Polyposis | 1 | PM | 32327909 | 📋 | Silymarin, Boswellic Acid and Curcumin Enriched Dietetic Formulation Reduces the Growth of Inherited Intestinal Polyps in an Animal Model |
| Silymarin | Huntington's Disease | 1 | PM | 36568269 | 📋 | Neuroprotective effect of silymarin against 3-Nitropropionic acid-induced neurotoxicity in rats |
| Silymarin | Thalassemia | 4 | PM | 35106163 | 📋 | Therapeutic potential of silymarin as a natural iron-chelating agent in β-thalassemia intermedia |
